The International Society of Nephrology (ISN), with its mission to improve kidney health worldwide and ensure that all people have equitable access to sustainable kidney health, has noted with alarming concern that President Donald Trump has formally moved to withdraw the US from the World Health Organization (WHO).
International Society of Nephrology - Advancing Clinical Trials (ISN-ACT) Statement on Trials and COVID-19
The ISN-ACT Committee has released a statement on the urgent need to include patients with kidney diseases in clinical trials related to COVID-19.
Despite preliminary studies demonstrating the increased risk for people with kidney diseases to develop severe COVID-19 symptoms or to die from COVID-19, kidney disease patients are frequently excluded from COVID-19-related clinical trials.
Effective therapies are needed to prevent and treat COVID-19 in all patients, including those with kidney diseases, and to reduce the current burden to healthcare systems.
Honoring the Past, Welcoming the Future: Experience the ISN Timeline
ISN Global Kidney Care Podcast
Focusing on topics of relevance to the nephrology community, currently the COVID-19 pandemic, the Global Kidney Care Podcast(GKCP) will cover the science, stories, and experiences that impact nephrologists and kidney healthcare professionals around the world.
As part of the ISN’s Collaboration Plan with the World Health Organization (WHO), the ISN i3C (International Consortium CKDu Collaborators) group has organized a platform to collect and store basic information on current human studies in CKDu.
The data is obtained from researchers and accessed through the ISN Observatory of CKDu, facilitating exchange of information and knowledge.
Kidney International (KI) is ISN's official journal, one of the most cited journals in nephrology and widely regarded as the world's premier journal on the development and consequences of kidney disease. KI is peer-reviewed and publishes original research in both basic science and clinical medicine covering renal physiology, biochemistry, pathology, immunology, morphology and more. It aims to inform the renal researcher and the practicing nephrologist on all aspects of renal studies, including basic and clinical research, emerging therapeutics, and novel diagnosis.
The ISN-ACT is an initiative of the ISN intended to leverage existing infrastructures within ISN, in order to improve global nephrology community participation in clinical trial research, through a series of activities and initiatives.
To generate more high-quality clinical trials and studies in nephrology, ISN-ACT (Advancing Clinical Trials) is calling on investigators and interested individuals to join this initiative. Let’s grow the capacity of the global nephrology community to lead and participate in clinical trials, by contributing to a range of initiatives, increasing collaboration and sharing experiences.
The aim of ISN-ACT is to increase the number of international high-quality clinical trials in nephrology, informing the optimal prevention and treatment of kidney disease and its complications for the benefit of patients.
Goals
ISN–ACT has several key goals:
To bring together people undertaking clinical trials and related studies in nephrology, in order to facilitate interaction, sharing of experiences, and collaboration
To provide a forum for the discussion of key scientific, operational and analytic issues facing clinical trial researchers in kidney disease
To grow the capacity of the global nephrology community to conduct high quality clinical trials and studies by connecting researchers with different levels of experience, and through specific training initiatives within the ISN framework
To develop ISN led and/or supported activities which help to standardise high-quality trial conduct in nephrology.
ISN-ACT Global Trials Focus (GTF)
On this page (see below) you will find the montly trials list, a short summary of important recent trials relevant to kidney disease, with links to the abstract.
This list can also be accessed on the ISN Academy e-learning platform here. Please click on the orange "sign in" button If you forgot your password, or have not established one yet, please contact the ISN Membership Department via membership@theisn.org
Core Group Members: Vlado Perkovic (Chair) Dick de Zeeuw Rhys Evans (YNC representative) Meg Jardine Vivek Jha Adeera Levin David Wheeler
Committee Members: Sanjay Agarwal Fatiu Arogundade Yingyos Avihingsanon Ricardo Correa-Rotter Thomas Hiemstra Meg Jardine Zhi-Hong Liu David Mudge Roberto Pecoits Filho Giuseppe Remuzzi Piero Ruggenenti Ifeoma Ulasi Angela Yee Moon Wang Hong Zhang
Focusing on topics of relevance to the nephrology community, currently the COVID-19 pandemic, the 
